Published in
Cellular Therapy and Transplantation, 1(10), p. 37-43, 2021
DOI: 10.18620/ctt-1866-8836-2021-10-1-37-43
Links
Tools
Nivolumab-based immunotherapy in relapsed/refractory B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma
Journal article published in 2021 by
Olesya G. Smykova,
Kirill Lepik,
Natalia B. Mikhailova,
Elena Kondakova,
Evgenia S. Borzenkova,
Elena E. Lepik,
Yuri R. Zalyalov,
Lilia Stelmakh,
Vadim Baykov,
Ivan S. Moiseev,
Alexander D. Kulagin 
,
Boris Afanasyev
,
Boris Afanasyev
